| Timothy Ryan Short, NP-C | |
|
146 S Charles St, Adrian, MI 49221-2556 | |
| (517) 366-5000 | |
| (517) 366-5002 |
| Full Name | Timothy Ryan Short |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 146 S Charles St, Adrian, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114696069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 4704335486 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emma L Bixby Medical Center | Adrian, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Promedica Central Corporation Of Michigan | 7012902265 | 108 |
News Archive
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.
It is generally recommended that a temporary stoma be closed within 9-12 wk after its construction. However, because some patients poorly tolerate the temporary stoma owing to extracellular dehydration, difficult pouch fitting, parenteral nutrition requirement in cases when the stoma is very proximal, and psychological or social impact, it might be advisable to opt for early closure.
International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.
The multicentre trial coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku shows that low socioeconomic status in childhood increases the risk of greater left ventricular mass and reduced diastolic function in adulthood.
› Verified 8 days ago
| Entity Name | Promedica Central Corporation Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588624696 PECOS PAC ID: 7012902265 Enrollment ID: O20040416001163 |
News Archive
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.
It is generally recommended that a temporary stoma be closed within 9-12 wk after its construction. However, because some patients poorly tolerate the temporary stoma owing to extracellular dehydration, difficult pouch fitting, parenteral nutrition requirement in cases when the stoma is very proximal, and psychological or social impact, it might be advisable to opt for early closure.
International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.
The multicentre trial coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku shows that low socioeconomic status in childhood increases the risk of greater left ventricular mass and reduced diastolic function in adulthood.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Ryan Short, NP-C 146 S Charles St, Adrian, MI 49221-2556 Ph: (517) 366-5000 | Timothy Ryan Short, NP-C 146 S Charles St, Adrian, MI 49221-2556 Ph: (517) 366-5000 |
News Archive
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.
It is generally recommended that a temporary stoma be closed within 9-12 wk after its construction. However, because some patients poorly tolerate the temporary stoma owing to extracellular dehydration, difficult pouch fitting, parenteral nutrition requirement in cases when the stoma is very proximal, and psychological or social impact, it might be advisable to opt for early closure.
International food import bills could exceed $1 trillion in 2010, the U.N. Food and Agriculture Organization (FAO) said Wednesday in its Food Outlook report, which found that wheat and other food staple prices have increased alarmingly over the past year, the Associated Press reports.
The multicentre trial coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku shows that low socioeconomic status in childhood increases the risk of greater left ventricular mass and reduced diastolic function in adulthood.
› Verified 8 days ago
Mr. Gregory Foltz, RN, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5640 N Adrian Hwy, Adrian, MI 49221 Phone: 517-577-0000 | |
Patricia Lynn Gray, R.N.C., W.H.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Lenawee County Health Department, 1040 South Winter Suite 2328, Adrian, MI 49221 Phone: 517-264-5233 Fax: 517-266-7804 | |
Rachel Redman, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 142 E Maumee St, Adrian, MI 49221 Phone: 517-920-7100 | |
Julia Lyn Winser, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 Sand Creek Hwy, Adrian, MI 49221 Phone: 517-263-6794 | |
Renee Vives, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2727 E Beecher St, Adrian, MI 49221 Phone: 517-265-3900 | |
Sarah Farmer, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 777 Kimole Ln, Suite 230, Adrian, MI 49221 Phone: 517-263-5655 Fax: 517-263-8012 |